992 resultados para Massachusetts in infantry. 45th regt., 1862-1863.


Relevância:

40.00% 40.00%

Publicador:

Resumo:

Bd. 5, Abt. 1, 2nd half, text

Relevância:

40.00% 40.00%

Publicador:

Resumo:

An online copy of a 1863 French book, The Scientific and Industrial Year (English translation of the title), that predates other historically significant writings about fingerprints suggests the use of iodine stains to reproduce papillary lines of the skin and suggests the feasibility of identifying suspects by touch. It also suggests the use of a magnifying glass for comparing those impressions whose origins need to be determined.

Relevância:

40.00% 40.00%

Publicador:

Resumo:

The following nomenclatural changes are made: Amastris convoluta (Fabricius, 1781) comb. nov. (formerly Darnis; Hebetica); Amastris maculata Funkhouser, 1922 = Amastris fasciata Broomfield, 1976 syn. nov. = Amastris pseudomaculata Broomfield, 1976 syn. nov. = Amastris inermis Broomfield, 1976 syn. nov. = Amastris sakakibarai Broomfield, 1976 syn. nov.; Amastris elevata Funkhouser, 1922 = Amastris vismiae Haviland, 1925 syn. nov. = Amastris flavifolia Funkhouser, 1927 syn. nov.

Relevância:

40.00% 40.00%

Publicador:

Resumo:

Doctoral dissertation, University of Helsinki

Relevância:

40.00% 40.00%

Publicador:

Resumo:

Background:The direct-acting platelet P2Y receptor antagonist ticagrelor can reduce the incidence of major adverse cardiovascular events when administered at hospital admission to patients with ST-segment elevation myocardial infarction (STEMI). Whether prehospital administration of ticagrelor can improve coronary reperfusion and the clinical outcome is unknown. Methods: We conducted an international, multicenter, randomized, double-blind study involving 1862 patients with ongoing STEMI of less than 6 hours' duration, comparing prehospital (in the ambulance) versus in-hospital (in the catheterization laboratory) treatment with ticagrelor. The coprimary end points were the proportion of patients who did not have a 70% or greater resolution of ST-segment elevation before percutaneous coronary intervention (PCI) and the proportion of patients who did not have Thrombolysis in Myocardial Infarction flow grade 3 in the infarct-related artery at initial angiography. Secondary end points included the rates of major adverse cardiovascular events and definite stent thrombosis at 30 days. Results: The median time from randomization to angiography was 48 minutes, and the median time difference between the two treatment strategies was 31 minutes. The two coprimary end points did not differ significantly between the prehospital and in-hospital groups. The absence of ST-segment elevation resolution of 70% or greater after PCI (a secondary end point) was reported for 42.5% and 47.5% of the patients, respectively. The rates of major adverse cardiovascular events did not differ significantly between the two study groups. The rates of definite stent thrombosis were lower in the prehospital group than in the in-hospital group (0% vs. 0.8% in the first 24 hours; 0.2% vs. 1.2% at 30 days). Rates of major bleeding events were low and virtually identical in the two groups, regardless of the bleeding definition used